Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Savara Inc (SVRA)  
$4.81 0.22 (4.79%) as of 4:30 Tue 5/14


Download
   
Exchange: American Stock Exchange
Security Type: Common
Shares Out: 135,340,000
Market Cap: 650.99(M)
Last Volume: 11,363,101 Avg Vol: 11,331,682
52 Week Range: $1.94 - $5.59
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    AMEX COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Savara is a clinical stage biopharmaceutical company focused on rare respiratory diseases. Co.'s primary program, molgramostim nebulizer solution is an inhaled biologic, specifically an inhaled granulocyte-macrophage colony-stimulating factor and is being developed for the treatment of autoimmune pulmonary alveolar proteinosis. Molgramostim nebulizer solution is administered once daily by inhalation via a nebulizer, the eFlow® Nebulizer System. The eFlow® Nebulizer System is a reusable electronic inhalation system. Molgramostim was also being investigated in cystic fibrosis (CF) and non-CF patients for the treatment of nontuberculous mycobacterial lung infection, a lung disorder.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 3,439,830 4,023,225
Total Buy Value $0 $0 $10,277,564 $11,106,809
Total People Bought 0 0 12 12
Total Buy Transactions 0 0 14 42
Total Shares Sold 0 187,843 187,843 187,843
Total Sell Value $0 $885,322 $885,322 $885,322
Total People Sold 0 3 3 3
Total Sell Transactions 0 3 3 3
End Date 2024-02-15 2023-11-14 2023-05-16 2022-05-16

   
Records found: 239
  Page 2 of 10  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Yang Rick 10% Owner   –       –       •   2023-07-17 4 B $3.00 $999,999 I/I 333,333 24,471,264 1.5 19%     
   Chang Carmen 10% Owner   –       –       •   2023-07-17 4 B $3.00 $999,999 I/I 333,333 24,471,264 1.5 19%     
   Sandell Scott D 10% Owner   –       –       •   2023-07-17 4 B $3.00 $999,999 I/I 333,333 24,471,264 1.5 19%     
   Mathers Edward T 10% Owner   –       –       •   2023-07-17 4 B $3.00 $999,999 I/I 333,333 24,471,264 1.5 19%     
   New Enterprise Associates 17, L.p. 10% Owner   –       –       •   2023-07-17 4 B $3.00 $999,999 D/D 333,333 24,471,264 2.45 19%     
   Baskett Forest 10% Owner   –       –       •   2023-07-17 4 B $3.00 $999,999 I/I 333,333 24,471,264 1.5 19%     
   Walker Paul Edward 10% Owner   –       –       •   2023-07-17 4 B $3.00 $999,999 I/I 333,333 24,471,264 1.5 19%     
   Pratt Raymond Dennis Chief Medical Officer   •       –      –    2023-06-26 4 B $2.93 $19,045 D/D 6,500 160,000 2.74 38%     
   Ramsay David A Director   –       •      –    2023-05-26 4 B $2.63 $97,599 D/D 37,124 2,201,142 2.39 42%     
   Ramsay David A Director   –       •      –    2023-05-25 4 B $2.57 $33,130 D/D 12,876 2,164,018 2.39 41%     
   Ramsay David A Director   –       •      –    2023-05-24 4 B $2.56 $127,800 D/D 50,000 2,151,142 2.39 39%     
   Lutz Robert Matthew Chief Operating Officer   •       –      –    2023-02-24 4 A $0.00 $0 D/D 140,000 140,000     -
   Ramsay David A Director   –       •      –    2022-12-30 4 B $1.55 $44,834 D/D 29,000 2,101,142 2.39 25%     
   Ramsay David A Director   –       •      –    2022-12-29 4 B $1.54 $10,752 D/D 7,000 2,072,142 2.39 24%     
   Ramsay David A Director   –       •      –    2022-12-28 4 B $1.50 $4,923 D/D 3,293 2,065,142 2.31 23%     
   Ramsay David A Director   –       •      –    2022-12-23 4 B $1.44 $22,665 D/D 15,707 2,061,849 2.39 35%     
   Ramsay David A Director   –       •      –    2022-12-22 4 B $1.48 $61,127 D/D 41,414 2,046,142 2.39 30%     
   Pratt Raymond Dennis Chief Medical Officer   •       –      –    2022-12-22 4 B $1.54 $5,402 D/D 3,500 153,500 2.74 30%     
   Ramsay David A Director   –       •      –    2022-12-20 4 B $1.48 $5,307 D/D 3,586 2,004,728 2.39 29%     
   Ramsay David A Director   –       •      –    2022-12-20 4 B $1.50 $20,759 D/D 13,830 2,001,142 2.39 29%     
   Ramsay David A Director   –       •      –    2022-12-19 4 B $1.49 $60,834 D/D 40,719 1,987,312 2.39 30%     
   Ramsay David A Director   –       •      –    2022-12-16 4 B $1.50 $512 D/D 341 1,946,593 2.31 24%     
   Pauls Matthew CHIEF EXECUTIVE OFFICER   •       •      –    2022-12-13 4 A $0.00 $0 D/D 325,000 1,046,354     -
   Lowrance David L CHIEF FINANCIAL OFFICER   •       –      –    2022-12-13 4 A $0.00 $0 D/D 100,000 242,793     -
   Elam Nevan C Director   –       •      –    2022-12-13 4 OE $0.65 $762 D/D 1,172 29,244     -
  239 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 2 of 10
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us